Patent · US Active

Chondrocyte therapeutic delivery system

US7927599B2 · kind B2 · utility

5Cited by

64References

16Claims

0Family size

Assignee

Ethicon, Inc. · US

Inventors

Brooks J. Story · Carlsbad, US
Francois Binette · Weymouth, US
M. E. Liesbeth Brown · Newton, US

Key dates

Filing date	Dec 4, 2008
Grant date	Apr 19, 2011
Priority date	—
Expiry date	Dec 4, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2533/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Systems and methods for modifying the environment of target cell using genetically altered chondrocytes are provided. The genetically engineered chondrocytes can be used to express a therapeutic agent in a subject, including in an environment typically associated with chondrocytes and in an environment not typically associated with chondrocytes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.